GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly becoming a prominent focus in medical investigation, largely due to its impressive impact on managing conditions such as second type diabetes and excess body fat. New research have shown that beyond glucose regulation, GLP-1 agonists offer potential for heart health and perhaps